Pamukcu Rifat has filed 4 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 1045 shares of Aprea Therapeutics, Inc. ($APRE) on June 05, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | Pamukcu Rifat | Director | A | Common Stock | 1045 | $0.00 | 19,554.0000 | 5,993,866 | 5.65% | 0.02% |
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | Pamukcu Rifat | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| June 20, 2024 | Aprea Therapeutics, Inc. | $APRE | Pamukcu Rifat | Director | A | Common Stock | 1045 | $0.00 | 18,509.0000 | 4,198,326 | 5.98% | 0.02% |
| June 20, 2024 | Aprea Therapeutics, Inc. | $APRE | Pamukcu Rifat | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 4,198,326 | 9999.99% | 0.10% |